Incentive Compensation and Severance Agreement Sample Contracts

AMENDED AND RESTATED INCENTIVE COMPENSATION AND SEVERANCE AGREEMENT
Incentive Compensation and Severance Agreement • March 28th, 2025 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances

This Amended and Restated Incentive Compensation and Severance Agreement, dated as of March 27, 2025, is by and between IMMUCELL CORPORATION, a Delaware corporation (the “Company”) and BOBBI JO BROCKMANN (the “Executive”), and replaces and supersedes in its entirety the Fourth Amended and Restated Incentive Compensation Agreement, dated as of March 27, 2024, by between the Company and the Executive.

View Source